Tag: Shows
Empire State Building In Partnership With iHeartMedia's Z100 To Kick Off Nightly Music-To-Light Shows

Empire State Building In Partnership With iHeartMedia's Z100 To Kick Off Nightly Music-To-Light Shows

NEW YORK, March 27, 2020 /PRNewswire/ -- Empire State Realty Trust, Inc. and iHeartMedia today announce their partnership to reach those sheltering at home with New York's ...

Lees verder
New Data Confirms Cardiac Dimensions' Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

New Data Confirms Cardiac Dimensions' Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Pooled Analysis of Prospective Studies Presented during Late Breaking Trials Session at CRT 2020 KIRKLAND, Washington, Feb. 25, 2020 /PRNewswire/ -- Cardiac Dimensions, a ...

Lees verder
PwC Health Research Institute Report Shows Social Determinants of Health Undermining Progress of Modern Medicine

PwC Health Research Institute Report Shows Social Determinants of Health Undermining Progress of Modern Medicine

Fifty-seven percent of consumers surveyed said their doctor had never discussed the important social factors affecting their health Without renewed urgency, PwC healthcare ...

Lees verder
MeRes100 BRS – the World's First Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffold – Shows Consistent Long-term Positive Safety With C

MeRes100 BRS – the World's First Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffold – Shows Consistent Long-term Positive Safety With C

LONDON, July 11, 2019 /PRNewswire/ -- Meril's recently CE-approved MeRes100, used for the treatment of de-novo coronary artery lesions, has demonstrated zero scaffold ...

Lees verder
New Study Shows that Nut Consumption May Help Improve Erectile Function

New Study Shows that Nut Consumption May Help Improve Erectile Function

REUS, Spain, June 28, 2019 /PRNewswire/ -- A recent study, partially supported by the INC and published in the journal Nutrients(1), observed a significant increase in erectile ...

Lees verder
Hole in the eWallet: Mobile Payment Apps Face Significant Challenges Engaging, Retaining Users, Shows CleverTap Benchmark Report

Hole in the eWallet: Mobile Payment Apps Face Significant Challenges Engaging, Retaining Users, Shows CleverTap Benchmark Report

With 77 percent average churn, immediate value and superior customer experience become critical competitive differentiators SAN FRANCISCO, Jan. 23, 2019 /PRNewswire/ -- Mobile ...

Lees verder
IARD Report Shows Leading Beer, Wine and Spirits Producers Have Reached Hundreds of Millions of People Across the Globe in Their Mission to Comba

IARD Report Shows Leading Beer, Wine and Spirits Producers Have Reached Hundreds of Millions of People Across the Globe in Their Mission to Comba

LONDON, September 10, 2018 /PRNewswire/ -- The 11 companies behind some of the world's most popular beer, wine, and spirits brands have forged new and innovative partnerships ...

Lees verder
Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Park

Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Park

LONDON, August 3, 2018 /PRNewswire/ -- Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet ...

Lees verder
Study Shows Intensive Blood Pressure Control Reduces Risk Of Mild Cognitive Impairment (MCI) And The Combined Risk Of MCI And Dementia

Study Shows Intensive Blood Pressure Control Reduces Risk Of Mild Cognitive Impairment (MCI) And The Combined Risk Of MCI And Dementia

Plus: - Genomic Analysis of Alzheimer's Study May Enable a Precision Medicine Approach CHICAGO, July 25, 2018 /PRNewswire/ -- Significant reductions in the risk of mild ...

Lees verder
Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Saxenda®

Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Saxenda®

VIENNA, May 24, 2018 /PRNewswire/ -- People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world ...

Lees verder
BizPress.nl